| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
BioRestorative Therapies, Inc.
13D/A
BRTX · 090655606
|
15.1% |
2/19/2025
Event 2/14/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.